Journal Information
Editorial
The Relevance of REMAP-ILD for Ibero-American Countries: A Randomized Embedded Multifactorial Adaptive Platform (REMAP) Trial in the Field of Interstitial Lung Diseases (ILDs)
Leticia Kawano-Douradoa,b,c,
, Maria Molina-Molinad,e, Jacobo Sellarese,f,g,h, Juan I. Enghelmayeri,j
Corresponding author
a Hcor Research Institute, Hcor Hospital, Sao Paulo, Brazil
b Pulmonary Division, Heart Institute (InCor), University of Sao Paulo, Sao Paulo, Brazil
c MAGIC Evidence Ecosystem Foundation, Oslo, Norway
d ILD Unit, Respiratory Department, University Hospital of Bellvitge, IDIBELL, Hospitalet de Llobregat, Spain
e Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBER), Spain
f Servei de Pneumologia, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain
g Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
h Facultat de Medicina, Universitat de Vic (UVIC), Vic, Spain
i Hospital de Clínicas, Universidad de Buenos Aires, Argentina
j Fundación FUNEF, Buenos Aires, Argentina
Ver más